← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE AND ZIDOVUDINE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2014-02-03
Drug application
- FDA Application #
ANDA203259- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LAMIVUDINE AND ZIDOVUDINE
- Generic name
- LAMIVUDINE AND ZIDOVUDINE
- Active ingredients
- LAMIVUDINE; ZIDOVUDINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- HETERO LABS LTD V
- Manufacturer
- Exelan Pharmaceuticals Inc.
- First approval
- 2014-02-03
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown